Cleared Traditional

K201951 - Cemented Origin Hip Stem

K201951 is the FDA 510(k) clearance for Cemented Origin Hip Stem by Signature Orthopaedics Pty, Ltd.. It is a Class 2 Orthopedic device (product code LZO) cleared through the Traditional 510(k) pathway after a 18-day FDA review.

K201951 · Signature Orthopaedics Pty, Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
18d
Days
Class 2
Risk

K201951 is an FDA 510(k) clearance for the Cemented Origin Hip Stem. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Signature Orthopaedics Pty, Ltd. (Lane Cove West, AU). The FDA issued a Cleared decision on July 31, 2020 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Signature Orthopaedics Pty, Ltd. devices

Submission Details

510(k) Number K201951 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2020
Decision Date July 31, 2020
Days to Decision 18 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 122d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 420
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K201951.
SMS Cementless Stem
K201673 · Medacta International S.A. · Sep 2020
Spartan Hip Stem
K192883 · Signature Orthopaedics Pty, Ltd. · Aug 2020
Corin Optimized Positioning System (OPS) Femoral
K193545 · Corin USA · Aug 2020
Biolox® delta Ceramic Heads, Biolox® delta Option Ceramic Heads MR Labeling
K200959 · Biomet UK, Ltd. · Jul 2020
Cemented TSI Hip Stem
K192024 · Signature Orthopaedics Pty, Ltd. · Jun 2020
M-Vizion Femoral Revision System Extension
K191816 · Medacta International S.A. · Apr 2020